These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26255588)

  • 1. Conformational Equilibrium of CDK/Cyclin Complexes by Molecular Dynamics with Excited Normal Modes.
    Floquet N; Costa MG; Batista PR; Renault P; Bisch PM; Raussin F; Martinez J; Morris MC; Perahia D
    Biophys J; 2015 Sep; 109(6):1179-89. PubMed ID: 26255588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms.
    Verkhivker GM
    Mol Biosyst; 2017 Oct; 13(11):2235-2253. PubMed ID: 28926061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.
    Wierød L; Rosseland CM; Lindeman B; Oksvold MP; Grøsvik H; Skarpen E; Huitfeldt HS
    Cell Prolif; 2007 Aug; 40(4):475-87. PubMed ID: 17635516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.
    Park H; Yeom MS; Lee S
    Chembiochem; 2004 Dec; 5(12):1662-72. PubMed ID: 15505811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slower CDK4 and faster CDK2 activation in the cell cycle.
    Zhang W; Liu Y; Jang H; Nussinov R
    Structure; 2024 Aug; 32(8):1269-1280.e2. PubMed ID: 38703777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.
    Zheng F; Quiocho FA
    J Biol Chem; 2013 Oct; 288(42):30682-30692. PubMed ID: 24022486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Conformational Dynamics and Expansion Underpin a Multi-Step Mechanism for Specific Binding of p27 with Cdk2/Cyclin A.
    Tsytlonok M; Hemmen K; Hamilton G; Kolimi N; Felekyan S; Seidel CAM; Tompa P; Sanabria H
    J Mol Biol; 2020 Apr; 432(9):2998-3017. PubMed ID: 32088186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
    Otyepka M; Bártová I; Kríz Z; Koca J
    J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
    Henri P; Prevel C; Pellerano M; Lacotte J; Stoebner PE; Morris MC; Meunier L
    Br J Dermatol; 2020 Mar; 182(3):678-689. PubMed ID: 31145809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6.
    Liang JD; Zhang YE; Qin F; Chen WN; Jiang WM; Fang Z; Liang XL; Zhang Q; Li J
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):302. PubMed ID: 38856753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of human CDK4 in complex with a D-type cyclin.
    Day PJ; Cleasby A; Tickle IJ; O'Reilly M; Coyle JE; Holding FP; McMenamin RL; Yon J; Chopra R; Lengauer C; Jhoti H
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4166-70. PubMed ID: 19237565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements.
    Liu S; Bolger JK; Kirkland LO; Premnath PN; McInnes C
    ACS Chem Biol; 2010 Dec; 5(12):1169-82. PubMed ID: 20843055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1.
    Aubry C; Wilson AJ; Emmerson D; Murphy E; Chan YY; Dickens MP; García MD; Jenkins PR; Mahale S; Chaudhuri B
    Bioorg Med Chem; 2009 Aug; 17(16):6073-84. PubMed ID: 19632122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM structure of the CDK2-cyclin A-CDC25A complex.
    Rowland RJ; Korolchuk S; Salamina M; Tatum NJ; Ault JR; Hart S; Turkenburg JP; Blaza JN; Noble MEM; Endicott JA
    Nat Commun; 2024 Aug; 15(1):6807. PubMed ID: 39122719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor-1 together with reactive oxygen species promotes the acceleration of cell cycle progression by up-regulating the cyclin E and CDK2 genes during high glucose-induced proliferation of vascular smooth muscle cells.
    Zhang X; Liu L; Chen C; Chi YL; Yang XQ; Xu Y; Li XT; Guo SL; Xiong SH; Shen MR; Sun Y; Zhang CS; Hu KM
    Cardiovasc Diabetol; 2013 Oct; 12():147. PubMed ID: 24119616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex.
    De Vivo M; Cavalli A; Bottegoni G; Carloni P; Recanatini M
    Proteins; 2006 Jan; 62(1):89-98. PubMed ID: 16292742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
    Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
    Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.